S&P 500   4,348.36 (-1.22%)
DOW   34,206.11 (-0.68%)
QQQ   359.90 (-1.27%)
AAPL   174.89 (-0.34%)
MSFT   321.18 (+0.13%)
META   298.69 (-0.33%)
GOOGL   131.47 (-1.70%)
AMZN   130.48 (-3.56%)
TSLA   257.72 (-1.85%)
NVDA   413.72 (-2.05%)
NIO   8.51 (-3.51%)
BABA   84.35 (-1.62%)
AMD   96.75 (-3.58%)
T   15.35 (-1.29%)
F   12.19 (-1.38%)
MU   68.51 (-1.68%)
CGC   0.80 (-8.20%)
GE   113.67 (-1.03%)
DIS   83.00 (+0.53%)
AMC   7.79 (-4.53%)
PFE   32.97 (-1.93%)
PYPL   58.86 (-3.29%)
NFLX   385.80 (-0.13%)
S&P 500   4,348.36 (-1.22%)
DOW   34,206.11 (-0.68%)
QQQ   359.90 (-1.27%)
AAPL   174.89 (-0.34%)
MSFT   321.18 (+0.13%)
META   298.69 (-0.33%)
GOOGL   131.47 (-1.70%)
AMZN   130.48 (-3.56%)
TSLA   257.72 (-1.85%)
NVDA   413.72 (-2.05%)
NIO   8.51 (-3.51%)
BABA   84.35 (-1.62%)
AMD   96.75 (-3.58%)
T   15.35 (-1.29%)
F   12.19 (-1.38%)
MU   68.51 (-1.68%)
CGC   0.80 (-8.20%)
GE   113.67 (-1.03%)
DIS   83.00 (+0.53%)
AMC   7.79 (-4.53%)
PFE   32.97 (-1.93%)
PYPL   58.86 (-3.29%)
NFLX   385.80 (-0.13%)
S&P 500   4,348.36 (-1.22%)
DOW   34,206.11 (-0.68%)
QQQ   359.90 (-1.27%)
AAPL   174.89 (-0.34%)
MSFT   321.18 (+0.13%)
META   298.69 (-0.33%)
GOOGL   131.47 (-1.70%)
AMZN   130.48 (-3.56%)
TSLA   257.72 (-1.85%)
NVDA   413.72 (-2.05%)
NIO   8.51 (-3.51%)
BABA   84.35 (-1.62%)
AMD   96.75 (-3.58%)
T   15.35 (-1.29%)
F   12.19 (-1.38%)
MU   68.51 (-1.68%)
CGC   0.80 (-8.20%)
GE   113.67 (-1.03%)
DIS   83.00 (+0.53%)
AMC   7.79 (-4.53%)
PFE   32.97 (-1.93%)
PYPL   58.86 (-3.29%)
NFLX   385.80 (-0.13%)
S&P 500   4,348.36 (-1.22%)
DOW   34,206.11 (-0.68%)
QQQ   359.90 (-1.27%)
AAPL   174.89 (-0.34%)
MSFT   321.18 (+0.13%)
META   298.69 (-0.33%)
GOOGL   131.47 (-1.70%)
AMZN   130.48 (-3.56%)
TSLA   257.72 (-1.85%)
NVDA   413.72 (-2.05%)
NIO   8.51 (-3.51%)
BABA   84.35 (-1.62%)
AMD   96.75 (-3.58%)
T   15.35 (-1.29%)
F   12.19 (-1.38%)
MU   68.51 (-1.68%)
CGC   0.80 (-8.20%)
GE   113.67 (-1.03%)
DIS   83.00 (+0.53%)
AMC   7.79 (-4.53%)
PFE   32.97 (-1.93%)
PYPL   58.86 (-3.29%)
NFLX   385.80 (-0.13%)
LON:ORPH

Open Orphan (ORPH) Share Forecast, Price & News

Compare
Today's Range
N/A
50-Day Range
10
10
52-Week Range
N/A
Volume
652,639 shs
Average Volume
1.56 million shs
Market Capitalization
£67.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ORPH stock logo

About Open Orphan (LON:ORPH) Stock

Open Orphan Plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, the company is developing a database of infectious disease progression data that include Disease in Motion platform, which comprises unique datasets, such as clinical, immunological, virological, and digital (wearable) biomarkers. The Disease in Motion platform has various potential applications across a range of end users, including big technology, wearables, pharma, and biotech companies. Further, the company provides pre­clinical and early clinical research services; sales and marketing services; and biometry, data management, and statistics to its various European pharmaceutical clients, as well as drug development consultancy and services, including CMC (chemistry, manufacturing, and controls), and PK and medical writing to a range of European clients. The company is headquartered in London, the United Kingdom.


ORPH Stock News Headlines

3 Words and a 3,000% Return
In October 2013, a scientist wrote 3 words on a piece of paper. They were simple words. A fiveyear-old could say them. But these three words could deliver you a 3,000% return in 2023 >>>
Open Orphan (LON:ORPH) Trading Up 5.3%
3 Words and a 3,000% Return
In October 2013, a scientist wrote 3 words on a piece of paper. They were simple words. A fiveyear-old could say them. But these three words could deliver you a 3,000% return in 2023 >>>
Lauren Groff Has Written a New Gospel
DC Confirms One Person Can Beat Cassandra Cain
Ahsoka: Who Is Ezra Bridger?
See More Headlines
Receive ORPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Open Orphan and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
179
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£34.71 million
Book Value
GBX 3.10 per share

Miscellaneous

Free Float
N/A
Market Cap
£67.09 million
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Cathal Martin Friel (Age 57)
    Exec. Chairman
  • Dr. Yamin Mohammed Khan Ph.D. (Age 52)
    CEO & Director
  • Mr. Leo Toole (Age 49)
    Group CFO & Director
  • John Sheridan
    Chief Operating Officer
  • Mr. Andrew Catchpole
    Chief Scientific Officer
  • Dr. Maurice N. Treacy Ph.D.
    Chief Commercial Officer













ORPH Stock - Frequently Asked Questions

What is Open Orphan's stock symbol?

Open Orphan trades on the London Stock Exchange (LON) under the ticker symbol "ORPH."

How do I buy shares of Open Orphan?

Shares of ORPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

How much money does Open Orphan make?

Open Orphan (LON:ORPH) has a market capitalization of £0.00 and generates £34.71 million in revenue each year.

How many employees does Open Orphan have?

The company employs 179 workers across the globe.

How can I contact Open Orphan?

Open Orphan's mailing address is Ole Maaloees Vej 3, Copenhagen N, Koebenhavn 2200. The official website for the company is www.openorphan.com. The company can be reached via phone at 353 1 644 0007.

This page (LON:ORPH) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -